Evidence map›Paper›PMID 25712807›Full record

ArticleScientific reports2015

ATP exhibits antimicrobial action by inhibiting bacterial utilization of ferric ions.

Yutaka Tatano, Yuichi Kanehiro, Chiaki Sano, Toshiaki Shimizu, Haruaki Tomioka

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Looking beyond Typical Treatments for Atypical Mycobacteria.Antibiotics (Basel, Switzerland) · 2020
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Shigella Iron Acquisition Systems and their Regulation.Frontiers in cellular and infection microbiology · 2016
    Review
  19. The Danger Signal Extracellular ATP Is an Inducer ofFrontiers in cellular and infection microbiology · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yutaka TatanoDepartment of Microbiology and Immunology, Shimane University School of Medicine, Izumo 693-8501, Japan.
Yuichi KanehiroDepartment of Microbiology and Immunology, Shimane University School of Medicine, Izumo 693-8501, Japan.
Chiaki SanoDepartment of Microbiology and Immunology, Shimane University School of Medicine, Izumo 693-8501, Japan.
Toshiaki ShimizuDepartment of Nutrition Administration, Yasuda Women's University, Hiroshima 231-0153, Japan.
Haruaki Tomioka1] Department of Microbiology and Immunology, Shimane University School of Medicine, Izumo 693-8501, Japan [2] Faculty of Nursing, Yasuda Women's University, Hiroshima 231-0153, Japan.
Shimane University · JPYasuda Women's University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

ATP up-regulates macrophage antimycobacterial activity in a P2X7-dependent manner, but little is known about whether ATP directly exhibits antimicrobial effects against intracellular mycobacteria. In this study, we found that ATP inhibited the growth of various bacteria, including Staphylococcus, Pseudomonas, and mycobacteria, without damaging bacterial surface structures. Using gene technology, we newly established an enterobactin-deficient (entB(-)) mutant from ATP-resistant Klebsiella pneumoniae, and found the recovery of ATP susceptibility in the enterobactin-deleted mutant. Therefore, ATP's antibacterial activity is attributable to its iron-chelating ability. Since ATP distributed in the cytosol of macrophages at high concentrations, ATP appears to augment macrophage's antimicrobial activity by directly attacking intracytosolic and intra-autophagosomal pathogens. Furthermore, ATP exhibited combined effects with some antimicrobials against methicillin-resistant S. aureus (MRSA) and M. intracellulare, suggesting its usefulness as an adjunctive drug in the chemotherapy of certain intractable infections.

Indexed as

Adenosine TriphosphateAnimalsAnti-Infective AgentsBacteriaDrug AntagonismDrug SynergismIonsIronIron Chelating AgentsMacrophagesMaleMiceMicrobial Sensitivity TestsMycobacteriumPhenotypeSiderophoresAdenosine TriphosphateAnti-Infective AgentsIonsIronIron Chelating AgentsSiderophores

Identifiers

PMID25712807
PMCPMC4339799
OpenAlexW2056069859

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.